Why Aptevo Therapeutics Stock Is Cratering
Why Aptevo Therapeutics Stock Is Cratering
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower Thursday after the company priced its $4.6 million public offering.
The Details:
Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its common stock at a purchase price of $1.35 per share.
Aptevo shares are dropping on heavy trading volume. According to data from Benzinga Pro, more than 3.8 million shares have been traded in the session, compared to the stock's 100-day average of slightly more than 138,000 shares.
Related News: What's Going On With Chinese EV Stocks Nio And XPeng?
APVO Stock Prediction 2024:
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Aptevo Therapeutics, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Aptevo Therapeutics, the 200-day moving average sits at $16.38, according to Benzinga Pro, which is above the current price of $1.05. For more on charts and trend lines, see a description here.
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
APVO Price Action: According to Benzinga Pro, Aptevo Therapeutics shares are down by more than 59% at $0.98 at the time of publication Thursday.
Image: james-yarema from Unsplash
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower Thursday after the company priced its $4.6 million public offering.
Aptevo Therapeutics Inc.（納斯達克股票代碼：APVO）股價週四走低，此前該公司對460萬美元的公開募股進行了定價。
The Details:
細節：
Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its common stock at a purchase price of $1.35 per share.
Aptevo宣佈將公開發行3,400,000股普通股或預先注資的認股權證以代替該股以及以每股1.35美元的收購價購買最多6,800,000股普通股的認股權證。
Aptevo shares are dropping on heavy trading volume. According to data from Benzinga Pro, more than 3.8 million shares have been traded in the session, compared to the stock's 100-day average of slightly more than 138,000 shares.
由於交易量大，Aptevo的股價正在下跌。根據Benzinga Pro的數據，該交易日已交易超過380萬股，而該股的100天平均交易量略高於13.8萬股。
Related News: What's Going On With Chinese EV Stocks Nio And XPeng?
相關新聞： 中國電動汽車股票蔚來和小鵬怎麼了？
APVO Stock Prediction 2024:
2024 年 APVO 股票預測：
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
華爾街內外的股票研究分析師通常使用收益增長和基礎研究作爲估值和預測的一種形式。但是，許多交易者將技術分析作爲形成股價走勢預測模型的一種方式。
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Aptevo Therapeutics, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Aptevo Therapeutics, the 200-day moving average sits at $16.38, according to Benzinga Pro, which is above the current price of $1.05. For more on charts and trend lines, see a description here.
一些投資者通過趨勢來幫助預測他們認爲股票在未來某個時刻的交易走向。從Aptevo Therapeutics來看，投資者可以使用移動平均線和趨勢線對股票的長期前景進行評估。如果他們認爲股票將保持在移動平均線上方（許多人認爲這是一個看漲信號），他們可以使用趨勢線將這種趨勢推斷到未來。根據Benzinga Pro的數據，Aptevo Therapeutics的200天移動平均線爲16.38美元，高於目前的1.05美元。有關圖表和趨勢線的更多信息，請參閱此處的描述。
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
交易者認爲，當股票高於其移動平均線時，這是一個普遍看漲的信號，而當它跌破移動平均線時，則是一個更加消極的信號。投資者可以使用趨勢線做出有根據的猜測，如果情況保持穩定，股票以後可以在哪裏交易。
APVO Price Action: According to Benzinga Pro, Aptevo Therapeutics shares are down by more than 59% at $0.98 at the time of publication Thursday.
APVO價格走勢：根據Benzinga Pro的數據，截至週四發佈時，Aptevo Therapeutics的股價下跌了59％以上，至0.98美元。
Image: james-yarema from Unsplash
圖片：來自 Unsplash 的 james-yarema
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧